Profit before interest, taxes and amortization: kaziatherapeutics.com (KZIA)

Graphic logo of Kazia Therapeutics Limited (KZIA)

Kazia Therapeutics (KZIA) develops breakthrough small molecules for the therapy of brain tumors. Current EBITDA figures reflect market volatility, where 0.00 expresses the latest level of the metric. R&D efficiency is increasing through cloud automation and AI data analysis. The startup's financial stability does not depend on macroeconomics but is determined exclusively by the success of clinical drug trials.

Kazia Therapeutics (KZIA) - Operating profit EBITDA from 11/23/2025 to 11/15/2026

Summary analytical data breakdowns for Kazia (KZIA)

- stock quotes and analyst forecast:
Price Performance Chart Kazia Therapeutics|KZIA - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Kazia Therapeutics Ltd|KZIA - Total Company Value
- book capitalization data:
Equity per Share Kazia Therapeutics|KZIA - Book Capitalization|Market Cap to Net Assets Ratio kaziatherapeutics.com|KZIA - Aggregate Company Assets
- debt level and financial liquidity data:
Debt to Capital Kazia Therapeutics|KZIA - Long-Term Debt to Equity|Short-Term Debt to Equity Kazia Therapeutics|KZIA - Company Debts|Debts to Book Value Kazia Therapeutics Limited|KZIA - Company Long-Term Debts|Short-Term Indebtedness Kazia Therapeutics|Immediate Liquidity kaziatherapeutics.com
- earnings and valuation multiples indicators:
KZIA - Net Income|Expected Net Income Kazia Therapeutics|KZIA - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Kazia|KZIA - PEG Multiple|Business Value to Operating Income Before Depreciation Kazia Therapeutics Limited|KZIA - Operating profit EBITDA|Net earnings per one share for the last twelve months Kazia Therapeutics|KZIA - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months kaziatherapeutics.com|KZIA - Earnings growth in current year|Earnings growth forecast for next year Kazia Therapeutics
- sales revenue and business income indicators:
KZIA - Company Revenue|Company Expected Revenue kaziatherapeutics.com|KZIA - Market Cap to Revenue|Market Cap to Future Revenue Ratio Kazia Therapeutics Ltd|KZIA - Sales Growth YoY (Last Twelve Months)
Analysis of all company metrics:Kazia Therapeutics
Manufactured product of Kazia Therapeutics Ltd

This indicator tracks daily operating profit before interest and taxes, allowing investors to monitor cash flow generation in real time. An analysis of EBITDA history reflects the capital management efficiency of Kazia Therapeutics (KZIA) under strict FDA oversight, where profit stability confirms the commercial value of the Paxalisib patents and the company's resilient position in oncology.

Who Kazia Therapeutics competes with

Income before deduction of interest, taxes and amortization INCY|HCM - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Nuvation Bio Inc|Day One (DAWN) - Profit before payment of interest, taxes and amortization|Operating profit before amortization MNPR|INBX (inhibrx.com) - Operating profit EBITDA|Operating profit before deduction of amortization i-mabbiopharma.com (IMAB)|Profit before payment of interest, taxes and amortization Fennec (FENC)|HRTX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Nuvectis NVCT|Coherus Biosciences - Profit before payment of interest, taxes and amortization|CRBP - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization cardiffoncology.com|BYSI: Operating profit EBITDA|Operating profit before depreciation charges BioAtla, Inc. BCAB|Operating profit before deduction of amortization LIXT|Profit before interest, taxes and amortization Citius Pharmaceuticals, Inc. CTXR|Operating profit before deduction of amortization CLRB (Cellectar Biosciences)|BLRX (BioLineRx) - Income before deduction of interest, taxes and amortization|Can-Fite BioPharma - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization APRE (Aprea)|Silexion Therapeutics - Operating profit EBITDA|Income before deduction of interest, taxes and amortization NCNA (nucana.com)|CMRX: Operating profit EBITDA|Profit before interest, taxes and amortization cyclacel.com (CYCC)|Profit before payment of interest, taxes and amortization g1therapeutics.com|KRON: Income before deduction of interest, taxes and amortization|Operating profit EBITDA KTRA|Operating profit EBITDA Oncternal Corp (ONCT)|Profit before payment of interest, taxes and amortization Portage PRTG